ISebe leHlabathi

Kwicandelo lehlabathi lokuchongwa nonyango lomhlaza wemiphunga, ukufunyanwa kwangethuba kunye nonyango oluchanekileyo lwee-nodules zemiphunga bekusoloko kuyinto ephambili kwingqwalaselo yezonyango. Njengezithunzi ezixineneyo kwimifanekiso yemiphunga, ii-nodules zemiphunga zahlukile ngokwemvelo, ukusuka ekuvuvukeni okungengobungozi ukuya ekuqaphelisweni kwangethuba...Funda ngokugqithisileyo»

Kuhambo lokulwa nomhlaza, uluntu lwezonyango belusoloko lufuna iindlela zonyango ezisebenzayo nezikhuselekileyo. Nangona utyando, unyango ngemitha, i-chemotherapy, kunye ne-biotherapy zibeke isiseko esiqinileyo sonyango lomhlaza, i-hyperthermia—iteknoloji yanamhlanje ephuma kubulumko bamandulo—...Funda ngokugqithisileyo»

Ukujongana nokuxilongwa komhlaza, ithemba elifanayo lezigulana kwihlabathi liphela kukufumana ukhetho lonyango olusebenzayo, oluphambili, nolungenazo izithintelo kangako. Ukuba ufuna isibhedlele esidibanisa ubuchule obuphezulu bezonyango zaseTshayina, iteknoloji yanamhlanje, kunye neenkonzo ezisemgangathweni zamazwe ngamazwe,...Funda ngokugqithisileyo»

Xa wena okanye umntu omthandayo ejongene nokuxilongwa komhlaza kwaye uzive ungenathemba okanye ungenathemba ngelixa ufuna iindlela zonyango zasekuhlaleni, ngaba ukhe uzibuze: Kwelinye icala lehlabathi, ngaba kukho iindlela zonyango eziphucukileyo, ezingangeni kakhulu, nezinethemba ngakumbi ezikhoyo? Ukuba unemibuzo malunga nonyango olutsha lomhlaza...Funda ngokugqithisileyo»

Isigulana esinesifo somhlaza wobuchopho esingapheliyo, esasiphinde sabuyela umva emva konyango lwe-CAR-T oluphindwe ka-17, sabona ithumba laso linyamalala ngokupheleleyo kwiiveki ezi-4 emva kokufumana unyango olutsha lwe-TIL kwaye sihlale singenaso ithumba kangangeenyanga ezingaphezu kwama-20. Ukuba unemibuzo malunga nonyango olutsha lomhlaza kunye novavanyo lweklinikhi: Ucingo: 4008803716 | WeChat:...Funda ngokugqithisileyo»

Ngomhla we-17 kweyeNkanga, ngo-2025, u-Abbisko ubhengeze umboniso wepowusta wokusebenza kakuhle kwexesha elide, ukhuseleko kunye neziphumo ezixeliweyo zezigulane ezivela kwiSigaba sesiThathu se-MANEUVER sehlabathi jikelele se-pimicotinib (ABSK021) kwizigulane ezine-tenosynovial giant cell tumor (TGCT) kwi-Connective Tissue Oncology Society (CTOS) ngo-2025 ...Funda ngokugqithisileyo»

Nge-8 kaSeptemba, ngo-2025, i-InnoCare Pharma ibhengeze ukuba i-HIBRUKA (orelabrutinib) ivunyiwe yi-Health Sciences Authority (HSA) yaseSingapore kunyango lwezigulane zabantu abadala abane-relapse okanye i-refractory marginal zone lymphoma (R/R MZL). Okwangoku, kusekho iimvavanyo ezininzi zeklinikhi ze-an...Funda ngokugqithisileyo»

Ngomhla wama-28 ku-Agasti, iZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration (i-NMPA) libhengeze ukuba i-BL-B01D1 yokujova icetywayo ukuba ifakwe kwinkqubo yokuphononongwa kwangaphambili. Yenzelwe izigulana ezine-carcinoma ye-nasopharyngeal ephindaphindayo okanye eguquguqukayo ezinesifo sangaphambi...Funda ngokugqithisileyo»

Ngomhla wama-21 ku-Agasti, i-epcoritamab, inikwe uphononongo oluphambili yiZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration (i-NMPA). Olu vunyiwe lujoliswe kwizigulana zabantu abadala abane-relapse okanye i-refractory follicular lymphoma (FL), icandelo elifunekayo kakhulu...Funda ngokugqithisileyo»

Nge-29 ka-Agasti, i-HERNEXEOS® kaBoehringer Ingelheim (iipilisi ze-zongertinib) ivunyiwe njenge-monotherapy yi-National Medical Products Administration (NMPA) yaseTshayina yokunyanga izigulane zabantu abadala abanomhlaza wemiphunga ongengoweseli encinci (i-NSCLC) ongenakususwa, oqhubekekayo okanye osasazekayo kwiiseli ezincinci zemiphunga (i-NSCLC) ezineethumba ezine ...Funda ngokugqithisileyo»

Ngomhla wama-22 ku-Agasti, ngo-2025, iDatopotamab deruxtecan (Dato-DXd; Datroway) ifumene imvume eTshayina yokunyanga izigulane zabantu abadala abane-receptor yehomoni engasuswayo okanye ene-metastatic, i-HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, okanye i-IHC 2+/in situ hybridization [ISH] negative) yebele...Funda ngokugqithisileyo»

Ngo-Agasti 2025, iZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration (i-NMPA) linike ngokusemthethweni i-Breakthrough Therapy Designation kwi-Ina-cel, unyango olutsha lweseli ye-CAR-T olukhokelwa yi-CD19 oluphuhliswe ngokuzimeleyo yiJuventas, lokunyanga izigulana zabantwana ezine-re...Funda ngokugqithisileyo»